Strategic Partnerships Leverage Quanterix Spatial capabilities and partnerships (e.g., ALZpath collaborations) to pursue co-developed research programs with pharma and diagnostics companies focused on Alzheimer’s and neurodegenerative diseases, expanding the addressable market beyond university labs.

Clinical Translation Highlight the transition from research to precision medicine by offering spatial biology workflows that support biomarker validation and clinical decision support, targeting biotech firms and CROs aiming to bring single-cell spatial insights into diagnostic pipelines.

Executive Talent Engage recent leadership hires (CMO, CFO, CCO) as a signal of strategic scale-up; tailor outreach to enterprise customers and strategic accounts seeking robust commercial and clinical program leadership to accelerate partnerships and large-scale deployments.

Financial Growth Position as a high-growth, mid-sized biotech with rising quarterly revenues and ongoing funding; propose multi-year collaboration or milestone-based programs with pharma/biotech firms that align with near-term revenue expansion and joint development efforts.

Technology Enablement Target customers with high-throughput imaging and biomarker needs by offering scalable spatial proteomics platforms integrated with their data workflows (CRM, ERP) and emphasize speed, single-cell resolution, and reproducibility to unlock research-to-clinical insights for drug development teams.